Commitments and Contingent Considerations (Details) ₪ in Thousands, $ in Thousands |
1 Months Ended | 3 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 01, 2020 |
Mar. 31, 2021
USD ($)
|
Mar. 31, 2021
ILS (₪)
|
Apr. 30, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2019
ILS (₪)
|
Apr. 30, 2019
USD ($)
|
Apr. 30, 2019
ILS (₪)
|
Mar. 31, 2021
USD ($)
|
Mar. 31, 2021
ILS (₪)
|
Apr. 30, 2020
ILS (₪)
|
|
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||
| Total budget | $ 5,874 | ₪ 19,444 | $ 4,287 | $ 3,123 | ₪ 10,794 | $ 1,185 | ₪ 15,562 | ||||
| Percentage of budget | 30.00% | 30.00% | 30.00% | 30.00% | 30.00% | 30.00% | 30.00% | ||||
| Received amount | $ 2,691 | $ 450 | $ 2,691 | ₪ 9,757 | ₪ 1,634 | ||||||
| Sale percentage, description | According to the agreement with the IIA, BiomX Israel will pay royalties of 3% to 3.5% of future sales up to an amount equal to the accumulated grant received including annual interest of LIBOR linked to the dollar. | ||||||||||
| Total grants | $ 6,212 | ₪ 21,863 | |||||||||
| Annual interest | $ 3,338 | ||||||||||
| Agreememnt, description | BiomX Israel entered into a research collaboration agreement with Boehringer Ingelheim International GmbH (“BI”) for a collaboration on biomarker discovery for inflammatory bowel disease (“IBD”). Under the agreement, BiomX Israel is eligible to receive fees totaling $439 in installments of $50 within 60 days of the Effective Date, $100 upon receipt of the BI materials, $150 upon the completion of data processing and $139 upon delivery of the Final Report of observations and Results of the Project (as such terms are defined within the agreement). Unless terminated earlier, this agreement will remain in effect until one year after the Effective Date or completion of the Project Plan (as defined in the agreement) and submission and approval of the Final Report. The Company implements ASU 2018-18, “Collaborative Arrangements (Topic 808),” with respect to this agreement. As of March 31, 2021, consideration of $300 had been received. | ||||||||||